|
|
||||
|
More compounds failing Phase I
Email: Anne Harding - anne_harding@yahoo.com News from The Scientist 2004, 5(1):20040806-03
|
||||
|
|
||||
|
Fewer drugs and biologics are making it from Phase 1 trials to the marketplace, which has dramatically pushed up the cost of drug development, Acting Food and Drug Administration (FDA) Commissioner Lester M. Crawford said in a speech to a group of institutional investment analysts last month.
|
|
|||||||||
|
|||||||||
|